EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC0

The effect of Nigella Sativa emulgel on episiotomy wound healing and pain intensity in primiparous women: A triple-blind randomized controlled trial

Effekt von Nigella sativa-Emulgel auf die Heilung von Episiotomiewunden und die Schmerzintensität bei primiparen Frauen: eine dreifach verblindete randomisierte kontrollierte Studie

Mahsa Maghalian, Afsaneh Alizadeh, Fatemeh Raphi, Ziba Islambulchilar, Laleh Khodaie, Mahsan Nabighadim, Simin Taghavi, Mojgan Mirghafourvand iD

PLOS One · 04.06.2025 · 20 (6) · e0325112

DOI: 10.1371/journal.pone.0325112 ↗

Auf einen Blick

Bei 74 primiparen Frauen verbesserte Nigella sativa-Emulgel die Episiotomiewundheilung und senkte die Schmerzen gegenüber Placebo. Die Zufriedenheit war höher.

Fragestellung

Wirkt Nigella sativa-Emulgel im Vergleich zu Placebo auf Wundheilung und Schmerz nach mediolateraler Episiotomie bei primiparen Frauen?

Methode

Dreifach verblindete, randomisierte kontrollierte Studie in Tabriz, Iran; topische Anwendung 3-mal täglich für 7 Tage nach Entlassung; Beurteilung bei Entlassung und 10 ± 1 Tage postpartal.

Ergebnisse

Mit Nigella sativa waren REEDA-Score (MD −0,79; 95 %-KI −1,20 bis −0,39; p = 0,001) und VAS-Schmerzscore (MD −0,74; 95 %-KI −1,3 bis −0,11; p = 0,021) niedriger als unter Placebo. Zufriedenheit: 86,5 % vs. 56,7 %; p = 0,046.

Einschränkungen

Laut Abstract werden größere multizentrische Studien zur breiteren Validierung benötigt.

Schlussfolgerung der Autor:innen

Topisches Nigella sativa-Emulgel verbesserte die Episiotomiewundheilung und reduzierte die Schmerzintensität; die Autor:innen sehen es als potenzielle natürliche Therapieoption.

Kernaussagen

  • REEDA-Score 10 ± 1 Tage postpartal günstiger als unter Placebo
  • VAS-Schmerzscore ebenfalls niedriger als unter Placebo
  • Keine unerwünschten Wirkungen berichtet; Zufriedenheit höher

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, online erschienen am 04.06.2025. Verfasst von Mahsa Maghalian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Wound Healing, Episiotomy, Nigella sativa, Postoperative Pain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Tabriz University of Medical Sciences.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Episiotomy, a common surgical procedure during childbirth, often leads to complications such as pain, infection, and delayed healing. Nigella sativa has demonstrated anti-inflammatory and wound-healing properties in prior studies and have received United States Food and Drug Administration (FDA) approval for food use, indicating their safety. This study aimed to evaluate the efficacy of Nigella sativa emulgel on episiotomy wound healing and pain intensity in primiparous women.

Methods

A triple-blind, randomized controlled trial was conducted at Taleghani Hospital, Tabriz, Iran (May 2023–April 2024). Seventy-four primiparous women with mediolateral episiotomy were randomized to receive either Nigella sativa emulgel or placebo, applied topically three times daily for 7 days post-discharge. Wound healing was assessed using the REEDA scale (Redness, Edema, Ecchymosis, Discharge, Approximation; primary outcome), and pain intensity was measured via visual analog scale (VAS; secondary outcome). Outcomes were evaluated at discharge (baseline) and 10 ± 1 days postpartum. Data were analyzed using independent t-tests, ANCOVA (adjusted for baseline scores), and Mann-Whitney U tests for non-normal distributions (SPSS v26).

Results

At 10 ± 1 days postpartum, the Nigella sativa group showed significantly better wound healing (REEDA score: MD −0.79, 95% CI −1.20 to −0.39; p = 0.001) and lower pain scores (VAS: MD −0.74, 95% CI −1.3 to −0.11; p = 0.021) compared to placebo. Subscale analysis revealed improvements in redness (p = 0.037), edema (p = 0.041), and ecchymosis (p = 0.043). No adverse effects were reported, and satisfaction was higher in the Nigella sativa group (86.5% vs. 56.7%; p = 0.046).

Conclusions

Topical Nigella sativa emulgel significantly improved episiotomy wound healing and reduced pain intensity, with high patient satisfaction. These findings support its potential as a natural therapeutic option, though larger multi-center trials are needed for broader validation.

Trial registration

Iranian Registry of Clinical Trials IRCT20120718010324N68 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wound HealingEpisiotomyNigella sativaPostoperative PainPlant ExtractsHumansFemaleAdultPregnancyPain MeasurementIranParityYoung AdultTreatment Outcome

Substanzen

Plant Extracts

Autor:innen und Institutionen

  • Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Midwifery, Faculty of Nursing and Midwifery, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Master of Midwifery, Clinical Research Development Unit, Taleghani Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Pharmaceutics, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Pharmacognosy, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Medicine student, Medical School, Ardabil University of Medical Sciences, Ardabil, Iran.

ORCID-Profile: Mojgan Mirghafourvand

Förderung

  • Tabriz University of Medical Sciences

Zitieren

APA

Maghalian, M., Alizadeh, A., Raphi, F., Islambulchilar, Z., Khodaie, L., Nabighadim, M., Taghavi, S., & Mirghafourvand, M. (2025). The effect of Nigella Sativa emulgel on episiotomy wound healing and pain intensity in primiparous women: A triple-blind randomized controlled trial. PLOS One, 20(6), e0325112. https://doi.org/10.1371/journal.pone.0325112

Vancouver

Maghalian M, Alizadeh A, Raphi F, Islambulchilar Z, Khodaie L, Nabighadim M, et al. The effect of Nigella Sativa emulgel on episiotomy wound healing and pain intensity in primiparous women: A triple-blind randomized controlled trial. PLOS One. 2025;20(6):e0325112. doi:10.1371/journal.pone.0325112

BibTeX
@article{Maghalian2025,
  author = {Maghalian, Mahsa and Alizadeh, Afsaneh and Raphi, Fatemeh and Islambulchilar, Ziba and Khodaie, Laleh and Nabighadim, Mahsan and Taghavi, Simin and Mirghafourvand, Mojgan},
  title = {The effect of Nigella Sativa emulgel on episiotomy wound healing and pain intensity in primiparous women: A triple-blind randomized controlled trial},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {6},
  pages = {e0325112},
  doi = {10.1371/journal.pone.0325112}
}
Kostenlos starten →